| RS139287714 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Inborn genetic diseases |
| RS139287784 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group P |
| RS139289675 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS139289704 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS139290300 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Arrhythmogenic right ventricular dysplasia 11 |
| RS139290621 |
NPHS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Steroid-resistant nephrotic syndrome, Focal segmental glomerulosclerosis |
| RS1392909108 |
BUB1B
|
Health Risk |
Pathogenic |
Premature chromatid separation trait, Mosaic variegated aneuploidy syndrome 1 |
| RS1392915838 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS139291592 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS1392921552 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1392934477 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS139293773 |
DNMT3A
|
Health Risk |
Likely pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS139293796 |
PKD1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139293893 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1392939514 |
ITGB4
|
Health Risk |
Pathogenic |
ITGB4-related disorder, ITGB4-related disorder |
| RS139293982 |
IFNAR1
|
Health Risk |
Likely risk allele |
Susceptibility to severe COVID-19, Susceptibility to severe COVID-19 |
| RS1392940377 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS139294220 |
RP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, RP1-related disorder |
| RS1392946940 |
ADNP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139295083 |
EOGT
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 4, Inborn genetic diseases |
| RS139295139 |
SEMA3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 16 with or without anosmia, Amenorrhea |
| RS1392954149 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS139295564 |
MYH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, proximal |
| RS139295905 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1392959973 |
GRIA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139297205 |
DLL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndactyly, Spondylocostal dysostosis 1 |
| RS139297216 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, DOCK8-related disorder |
| RS139297339 |
SLC4A11
|
Health Risk |
Conflicting classifications of pathogenicity |
Corneal dystrophy-perceptive deafness syndrome, Corneal dystrophy |
| RS139297616 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1392981001 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1392985639 |
TMEM67
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS139299149 |
IQCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Senior-Loken syndrome 5, Nephronophthisis |
| RS139299227 |
MVK
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperimmunoglobulin D with periodic fever, Mevalonic aciduria |
| RS1392992564 |
RBP3
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS139299777 |
NDUFV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS1392999374 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS139300551 |
GLDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Glycine encephalopathy |
| RS139300604 |
CERKL
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 26 |
| RS139300715 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, SCN1A-related disorder |
| RS139300843 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2C, Charcot-Marie-Tooth disease axonal type 2C |
| RS139301835 |
SERAC1
|
Health Risk |
Likely pathogenic |
3-methylglutaconic aciduria with deafness, encephalopathy |
| RS139302211 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1393024469 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS139302633 |
CDHR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 15, Cone-rod dystrophy 15 |
| RS139302890 |
CNOT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139302994 |
SLC34A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive hypophosphatemic bone disease, Autosomal recessive hypophosphatemic bone disease |
| RS139303296 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Inborn genetic diseases |
| RS1393039920 |
LIPA
|
Health Risk |
Likely pathogenic |
Lysosomal acid lipase deficiency, Lysosomal acid lipase deficiency |
| RS139304412 |
CLCNKB
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 3, Bartter disease type 4B |
| RS1393048121 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, 6 conditions |
| RS139304906 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS1393051955 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Inborn genetic diseases |
| RS139305531 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS139306043 |
ETFDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple acyl-CoA dehydrogenase deficiency, ETFDH-related disorder |
| RS1393064503 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 |
| RS1393065957 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS139306706 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS139306713 |
OBSCN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1393076582 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1393079124 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS139308059 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139308429 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS139308660 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant distal renal tubular acidosis, Hereditary spherocytosis type 4 |
| RS139309224 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS1393095176 |
GCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139309795 |
AGMO
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1393100780 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypercholesterolemia |
| RS1393101824 |
HSPG2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS139310305 |
SLC3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystinuria, Cystinuria |
| RS139310448 |
SCNN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Bronchiectasis with or without elevated sweat chloride 1, Pseudohypoaldosteronism |
| RS139310513 |
PTCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139310551 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, EP300-related disorder |
| RS1393117824 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast carcinoma, Familial cancer of breast |
| RS139311927 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS139312280 |
POU4F3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139312819 |
DNAJC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS139313647 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS139313781 |
COG6
|
Health Risk |
Conflicting classifications of pathogenicity |
COG6-congenital disorder of glycosylation, Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome |
| RS139314192 |
XPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139314808 |
TJP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS139315125 |
PER3
|
Health Risk |
Conflicting classifications of pathogenicity |
Advanced sleep phase syndrome 3, Advanced sleep phase syndrome 3 |
| RS1393160852 |
NRAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal-onset seizure, Focal-onset seizure |
| RS1393162163 |
DPAGT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 13, DPAGT1-congenital disorder of glycosylation |
| RS1393167436 |
TOE1
|
Health Risk |
Pathogenic |
— |
| RS1393167652 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 9 |
| RS139317626 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS139317695 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS139317756 |
DNAJB13
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 34, DNAJB13-related disorder |
| RS139317762 |
EDNRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hirschsprung disease, susceptibility to |
| RS139318016 |
KCNH1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1393181351 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS139318203 |
RPL23
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1393186135 |
DHCR7
|
Health Risk |
Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS139318648 |
DUSP6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 19 with or without anosmia, Hypogonadotropic hypogonadism 19 with or without anosmia |
| RS139318843 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa dystrophica, Transient bullous dermolysis of the newborn |
| RS139318945 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiomyopathy |
| RS139319094 |
SLC1A4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139319145 |
KCTD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1393191930 |
OTOG
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1393195833 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |